Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 681

1.

Pilot feasibility study of a home-based fall prevention exercise program (StandingTall) delivered through a tablet computer (iPad) in older people with dementia.

Taylor ME, Close JCT, Lord SR, Kurrle SE, Webster L, Savage R, Delbaere K.

Australas J Ageing. 2019 Sep 19. doi: 10.1111/ajag.12717. [Epub ahead of print]

PMID:
31538401
2.

Quantifying adherence to antihypertensive medication for chronic hypertension during pregnancy.

Webster LM, Reed K, Myers JE, Burns A, Gupta P, Patel P, Wiesender C, Seed PT, Nelson-Piercy C, Chappell LC.

Pregnancy Hypertens. 2019 Jul;17:12-14. doi: 10.1016/j.preghy.2019.05.004. Epub 2019 May 3.

PMID:
31487627
3.

The association of pain interference and opioid use with healthcare utilization and costs, and wage loss among adults with osteoarthritis in the United States.

Zhao X, Shah D, Gandhi K, Wei W, Dwibedi N, Webster L, Sambamoorthi U.

J Med Econ. 2019 Sep 9:1-10. doi: 10.1080/13696998.2019.1658590. [Epub ahead of print]

PMID:
31433685
4.

Clinical, humanistic, and economic burden of osteoarthritis among noninstitutionalized adults in the United States.

Zhao X, Shah D, Gandhi K, Wei W, Dwibedi N, Webster L, Sambamoorthi U.

Osteoarthritis Cartilage. 2019 Jul 9. pii: S1063-4584(19)31126-4. doi: 10.1016/j.joca.2019.07.002. [Epub ahead of print]

PMID:
31299387
5.

Older People with Dementia Have Reduced Daily-Life Activity and Impaired Daily-Life Gait When Compared to Age-Sex Matched Controls.

Taylor ME, Brodie MA, van Schooten KS, Delbaere K, Close JCT, Payne N, Webster L, Chow J, McInerney G, Kurrle SE, Lord SR.

J Alzheimers Dis. 2019 Jun 24. doi: 10.3233/JAD-181174. [Epub ahead of print]

PMID:
31256122
6.

Dilemma of Addiction and Respiratory Depression in the Treatment of Pain: A Prototypical Endomorphin as a New Approach.

Webster L, Schmidt WK.

Pain Med. 2019 Jun 5. pii: pnz122. doi: 10.1093/pm/pnz122. [Epub ahead of print]

PMID:
31165885
7.

Relative Oral Bioavailability of an Abuse-Deterrent, Immediate-Release Formulation of Oxycodone, Oxycodone ARIR in a Randomized Study.

Webster LR, Kinzler ER, Pantaleon C, Iverson M, Aigner S.

Adv Ther. 2019 Jul;36(7):1730-1740. doi: 10.1007/s12325-019-00963-0. Epub 2019 May 7.

PMID:
31065992
8.

Desmetramadol Has the Safety and Analgesic Profile of Tramadol Without Its Metabolic Liabilities: Consecutive Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trials.

Zebala JA, Searle SL, Webster LR, Johnson MS, Schuler AD, Maeda DY, Kahn SJ.

J Pain. 2019 Apr 18. pii: S1526-5900(18)30815-0. doi: 10.1016/j.jpain.2019.04.005. [Epub ahead of print]

9.

DNA barcoding validates species labelling of certified seafood.

Barendse J, Roel A, Longo C, Andriessen L, Webster LMI, Ogden R, Neat F.

Curr Biol. 2019 Mar 18;29(6):R198-R199. doi: 10.1016/j.cub.2019.02.014.

10.

Real-world misuse, abuse, and dependence of abuse-deterrent versus non-abuse-deterrent extended-release morphine in Medicaid non-cancer patients.

Cicero TJ, Mendoza M, Cattaneo M, Dart RC, Mardekian J, Polson M, Roland CL, Schnoll SH, Webster LR, Park PW.

Postgrad Med. 2019 Apr;131(3):225-229. doi: 10.1080/00325481.2019.1585688. Epub 2019 Mar 19.

PMID:
30794760
11.

Effects of intravenous oxycodone alone or in combination with naltrexone on measures of respiratory depression: a randomized placebo-controlled study.

Bass A, Webster LR, Matschke KT, Malhotra BK, Wolfram G.

Ther Adv Drug Saf. 2019 Feb 1;10:2042098618821274. doi: 10.1177/2042098618821274. eCollection 2019.

12.

Cell Proliferation receives its highest ever Impact Factor of 4.936 and transitions to Open Access.

Webster L.

Cell Prolif. 2019 Jan;52(1):e12561. doi: 10.1111/cpr.12561. No abstract available.

PMID:
30694005
13.

A nasal abuse potential randomized clinical trial of REMOXY® ER, a high-viscosity extended-release oxycodone formulation.

Friedmann N, Marsman MR, de Kater AW, Burns LH, Webster LR.

J Opioid Manag. 2018 Nov/Dec;14(6):437-443. doi: 10.5055/jom.2018.0476.

PMID:
30629280
14.

Heritability, SNP, inbreeding, dairy cattle, genomic selection-and other keywords.

Mäki-Tanila A, Webster L.

J Anim Breed Genet. 2019 Jan;136(1):1-2. doi: 10.1111/jbg.12377. No abstract available.

PMID:
30588727
15.

The 9th Santorini Conference: Systems Medicine, Personalised Health and Therapy. "The Odyssey from Hope to Practice", Santorini, Greece, 30 September⁻3 October 2018.

Visvikis-Siest S, Gorenjak V, Stathopoulou MG, Petrelis AM, Weryha G, Masson C, Hiegel B, Kumar S, Barouki R, Boerwinkle E, Dagher G, Deloukas P, Innocenti F, Lamont J, Marschler M, Meyer H, Meyer UA, Nofziger C, Paulmichl M, Vacher C, Webster L.

J Pers Med. 2018 Dec 12;8(4). pii: E43. doi: 10.3390/jpm8040043.

16.

A manual-based intervention for carers of people with dementia and sleep disturbances: an acceptability and feasibility RCT.

Kinnunen KM, Rapaport P, Webster L, Barber J, Kyle SD, Hallam B, Cooper C, Horsley R, Pickett JA, Vikhanova A, Espie CA, Livingston G.

Health Technol Assess. 2018 Dec;22(71):1-408. doi: 10.3310/hta22710.

17.

Adult report of childhood imaginary companions and adversity relates to concurrent prodromal psychosis symptoms.

Davis PE, Webster LAD, Fernyhough C, Ralston K, Kola-Palmer S, Stain HJ.

Psychiatry Res. 2019 Jan;271:150-152. doi: 10.1016/j.psychres.2018.11.046. Epub 2018 Nov 20.

18.

Uncritical Publication of a Biased Study Leads to Misleading Media Reports.

Webster LR.

Pain Med. 2018 Nov 20. doi: 10.1093/pm/pny234. [Epub ahead of print] No abstract available.

PMID:
30462306
19.
20.

An intervention to improve sleep for people living with dementia: Reflections on the development and co-production of DREAMS:START (Dementia RElAted Manual for Sleep: STrAtegies for RelaTives).

Rapaport P, Webster L, Horsley R, Kyle SD, Kinnunen KM, Hallam B, Pickett J, Cooper C, Espie CA, Livingston G.

Dementia (London). 2018 Nov;17(8):976-989. doi: 10.1177/1471301218789559.

PMID:
30373463
21.

Impact of ethnicity on adverse perinatal outcome in women with chronic hypertension: a cohort study.

Webster LM, Bramham K, Seed PT, Homsy M, Widdows K, Webb AJ, Nelson-Piercy C, Magee L, Thilaganathan B, Myers JE, Chappell LC.

Ultrasound Obstet Gynecol. 2019 Jul;54(1):72-78. doi: 10.1002/uog.20132.

PMID:
30318830
22.

Extended-release morphine sulfate and naltrexone hydrochloride (EMBEDA): naltrexone-associated withdrawal and abuse-related effects in patients with chronic pain and recreational opioid users.

Setnik B, Sommerville KW, Pixton GC, Webster L.

Curr Med Res Opin. 2019 Mar;35(3):503-512. doi: 10.1080/03007995.2018.1533457. Epub 2018 Nov 20.

PMID:
30293449
23.

Development of Chemical Proteomics for the Folateome and Analysis of the Kinetoplastid Folateome.

Webster LA, Thomas M, Urbaniak M, Wyllie S, Ong H, Tinti M, Fairlamb AH, Boesche M, Ghidelli-Disse S, Drewes G, Gilbert IH.

ACS Infect Dis. 2018 Oct 12;4(10):1475-1486. doi: 10.1021/acsinfecdis.8b00097. Epub 2018 Sep 28.

24.

DREAMS-START (Dementia RElAted Manual for Sleep; STrAtegies for RelaTives) for people with dementia and sleep disturbances: a single-blind feasibility and acceptability randomized controlled trial.

Livingston G, Barber JA, Kinnunen KM, Webster L, Kyle SD, Cooper C, Espie CA, Hallam B, Horsley R, Pickett J, Rapaport P.

Int Psychogeriatr. 2019 Feb;31(2):251-265. doi: 10.1017/S1041610218000753. Epub 2018 Sep 17.

25.

Distinct spin-lattice and spin-phonon interactions in monolayer magnetic CrI3.

Webster L, Liang L, Yan JA.

Phys Chem Chem Phys. 2018 Sep 19;20(36):23546-23555. doi: 10.1039/c8cp03599g.

PMID:
30183024
26.

What is the evidence for using labetalol as a first-line treatment option for hypertension in pregnancy?

Webster LM, Webb AJ, Chappell LC.

Drug Ther Bull. 2018 Sep;56(9):107-111. doi: 10.1136/dtb.2018.9.000008. Epub 2018 Aug 27. Review. No abstract available.

PMID:
30154139
27.

Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain.

Webster LR, Israel RJ.

J Pain Res. 2018 Aug 13;11:1503-1510. doi: 10.2147/JPR.S160488. eCollection 2018.

28.

No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Methadone in Participants Receiving Maintenance Opioid Agonist Therapy.

Feng HP, Guo Z, Caro L, Marshall WL, Liu F, Panebianco D, Vaddady P, Reitmann C, Jumes P, Wolford D, Fraser I, Valesky R, Martinho M, Butterton JR, Iwamoto M, Webster L, Yeh WW.

Clin Transl Sci. 2018 Nov;11(6):553-561. doi: 10.1111/cts.12564. Epub 2018 Jul 24.

29.

No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy.

Feng HP, Guo Z, Caro L, Marshall WL, Liu F, Panebianco D, Vaddady P, Barbour A, Reitmann C, Jumes P, Gilmartin J, Wolford D, Valesky R, Martinho M, Butterton JR, Iwamoto M, Fraser I, Webster L, Yeh WW.

Clin Transl Sci. 2018 Nov;11(6):562-572. doi: 10.1111/cts.12565. Epub 2018 Jul 24.

30.

Evaluation of the analgesic efficacy of AZD1940, a novel cannabinoid agonist, on post-operative pain after lower third molar surgical removal.

Kalliomäki J, Segerdahl M, Webster L, Reimfelt A, Huizar K, Annas P, Karlsten R, Quiding H.

Scand J Pain. 2013 Jan 1;4(1):17-22. doi: 10.1016/j.sjpain.2012.08.004.

PMID:
29913883
31.

Efficacy of Lubiprostone for the Treatment of Opioid-Induced Constipation, Analyzed by Opioid Class.

Webster LR, Brewer RP, Lichtlen P, Losch-Beridon T, Mareya S, Wang M.

Pain Med. 2018 Jun 1;19(6):1195-1205. doi: 10.1093/pm/pnx212.

PMID:
29897589
32.

Evaluating and managing chronic idiopathic urticaria in adults.

Webster L, Rider NL, Archambault ME.

JAAPA. 2018 Jul;31(7):22-26. doi: 10.1097/01.JAA.0000534976.46365.11. Review.

PMID:
29889715
33.

Intranasal Pharmacokinetics of Morphine ARER, a Novel Abuse-Deterrent Formulation: Results from a Randomized, Double-Blind, Four-Way Crossover Study in Nondependent, Opioid-Experienced Subjects.

Webster LR, Pantaleon C, Iverson M, Smith MD, Kinzler ER, Aigner S.

Pain Res Manag. 2018 Apr 23;2018:7276021. doi: 10.1155/2018/7276021. eCollection 2018.

34.

Identifying diabetes cases from administrative data: a population-based validation study.

Lipscombe LL, Hwee J, Webster L, Shah BR, Booth GL, Tu K.

BMC Health Serv Res. 2018 May 2;18(1):316. doi: 10.1186/s12913-018-3148-0.

35.

Profiling in wildlife crime: Recovery of human DNA deposited outside.

Mcleish K, Ferguson S, Gannicliffe C, Campbell S, Thomson PIT, Webster LMI.

Forensic Sci Int Genet. 2018 Jul;35:65-69. doi: 10.1016/j.fsigen.2018.04.002. Epub 2018 Apr 4.

PMID:
29673693
36.

A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Intranasal Human Abuse Potential Study of Oxycodone ARIR, a Novel, Immediate-Release, Abuse-Deterrent Formulation.

Webster LR, Iverson M, Pantaleon C, Smith MD, Kinzler ER, Aigner S.

Pain Med. 2019 Apr 1;20(4):747-757. doi: 10.1093/pm/pny043.

37.

Monitoring of Polycyclic Aromatic Hydrocarbons (PAHs) in Scottish Deepwater environments.

Webster L, Russell M, Shepherd N, Packer G, Dalgarno EJ, Neat F.

Mar Pollut Bull. 2018 Mar;128:456-459. doi: 10.1016/j.marpolbul.2018.01.049. Epub 2018 Feb 6.

PMID:
29571396
38.

The effect of labetalol and nifedipine MR on blood pressure in women with chronic hypertension in pregnancy.

Shawkat E, Mistry H, Chmiel C, Webster L, Chappell L, Johnstone ED, Myers JE.

Pregnancy Hypertens. 2018 Jan;11:92-98. doi: 10.1016/j.preghy.2017.12.007. Epub 2018 Jan 2.

PMID:
29523282
39.

Chronic hypertension in pregnancy: impact of ethnicity and superimposed preeclampsia on placental, endothelial, and renal biomarkers.

Webster LM, Gill C, Seed PT, Bramham K, Wiesender C, Nelson-Piercy C, Myers JE, Chappell LC.

Am J Physiol Regul Integr Comp Physiol. 2018 Jul 1;315(1):R36-R47. doi: 10.1152/ajpregu.00139.2017. Epub 2018 Mar 7.

40.

Performance and precision of double digestion RAD (ddRAD) genotyping in large multiplexed datasets of marine fish species.

Maroso F, Hillen JEJ, Pardo BG, Gkagkavouzis K, Coscia I, Hermida M, Franch R, Hellemans B, Van Houdt J, Simionati B, Taggart JB, Nielsen EE, Maes G, Ciavaglia SA, Webster LMI, Volckaert FAM, Martinez P, Bargelloni L, Ogden R; AquaTrace Consortium.

Mar Genomics. 2018 Jun;39:64-72. doi: 10.1016/j.margen.2018.02.002. Epub 2018 Feb 27.

PMID:
29496460
41.

Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: a randomized, double-blind, placebo-controlled phase 3 study.

Webster LR, Nalamachu S, Morlion B, Reddy J, Baba Y, Yamada T, Arjona Ferreira JC.

Pain. 2018 May;159(5):987-994. doi: 10.1097/j.pain.0000000000001174.

42.

Loss of Trust and Empathy Ends an Era of Opioid Self-Assessment.

Webster LR.

Pain Med. 2018 Feb 5. doi: 10.1093/pm/pny010. [Epub ahead of print] No abstract available.

PMID:
29415168
43.

Effect of Electrophysiology Assessment on Mortality and Hospitalizations in Patients With New-Onset Atrial Fibrillation.

Singh SM, Webster L, Qiu F, Austin PC, Ko DT, Tu JV, Wijeysundera HC.

Am J Cardiol. 2018 Apr 1;121(7):830-835. doi: 10.1016/j.amjcard.2017.12.031. Epub 2018 Jan 9.

PMID:
29397105
44.

Longitudinal changes in vascular function parameters in pregnant women with chronic hypertension and association with adverse outcome: a cohort study.

Webster LM, Myers JE, Nelson-Piercy C, Mills C, Watt-Coote I, Khalil A, Seed PT, Cruickshank JK, Chappell LC.

Ultrasound Obstet Gynecol. 2019 May;53(5):638-648. doi: 10.1002/uog.19021. Epub 2019 Mar 14.

PMID:
29380922
45.

Human abuse potential studies of abuse-deterrent opioids: lessons from oral and intranasal studies with morphine abuse-deterrent, extended-release, injection-molded tablets.

Webster LR, Viscusi ER, Brown C, Dayno JM.

Curr Med Res Opin. 2018 May;34(5):893-901. doi: 10.1080/03007995.2018.1433144. Epub 2018 Feb 8. Review.

PMID:
29368961
46.

Synthesis and antiproliferative activity of a series of new platinum and palladium diphosphane complexes.

Cullinane C, Deacon GB, Drago PR, Erven AP, Junk PC, Luu J, Meyer G, Schmitz S, Ott I, Schur J, Webster LK, Klein A.

Dalton Trans. 2018 Feb 6;47(6):1918-1932. doi: 10.1039/c7dt04615d.

PMID:
29340396
47.

Discerning suicide in drug intoxication deaths: Paucity and primacy of suicide notes and psychiatric history.

Rockett IRH, Caine ED, Connery HS, D'Onofrio G, Gunnell DJ, Miller TR, Nolte KB, Kaplan MS, Kapusta ND, Lilly CL, Nelson LS, Putnam SL, Stack S, Värnik P, Webster LR, Jia H.

PLoS One. 2018 Jan 10;13(1):e0190200. doi: 10.1371/journal.pone.0190200. eCollection 2018.

48.

Interpreting labels of abuse-deterrent opioid analgesics.

Webster LR.

J Opioid Manag. 2017 Nov/Dec;13(6):415-423. doi: 10.5055/jom.2017.0418. Review.

PMID:
29308588
49.

Insights and issues from FDA Advisory Committee meetings on abuse-deterrent opioids.

Miller CJ, Dart RC, Katz NP, Webster LR.

J Opioid Manag. 2017 Nov/Dec;13(6):379-389. doi: 10.5055/jom.2017.0416. Review.

PMID:
29308585
50.

From the Editor: Doctor driven problem or doctor driven solution?

Webster L.

J Opioid Manag. 2017 Nov/Dec;13(6):351-352. doi: 10.5055/jom.2017.0411. No abstract available.

PMID:
29308580

Supplemental Content

Loading ...
Support Center